NAD+ (Injectable)

Research ChemicalModerate Research

Also known as: NAD+ IV · NAD+ Injection · Nicotinamide Adenine Dinucleotide Injectable · NAD+ SubQ

Direct injectable form of NAD+ that bypasses oral bioavailability limitations, rapidly restoring cellular NAD+ levels to support mitochondrial function, DNA repair, and sirtuin activation.

Overview

Injectable NAD+ delivers nicotinamide adenine dinucleotide directly into the body via subcutaneous or intravenous routes, bypassing the significant bioavailability limitations of oral NAD+ precursors like NMN and NR. NAD+ is a critical coenzyme found in every living cell, essential for over 500 enzymatic reactions including energy metabolism, DNA repair, gene expression, and cellular signaling. NAD+ levels decline approximately 50% between ages 40 and 60, contributing to mitochondrial dysfunction, impaired DNA repair, decreased sirtuin activity, and accelerated aging. While oral precursors (NMN, NR) must undergo multi-step conversion to NAD+, injectable NAD+ provides the molecule directly, achieving rapid and significant elevation of tissue NAD+ levels. IV NAD+ infusions typically take 2-4 hours due to the need for slow administration to minimize side effects, while subcutaneous injections offer a more practical daily option. Clinical applications include anti-aging protocols, neurodegenerative support, addiction recovery, chronic fatigue, and metabolic optimization.

Many practitioners report that injectable NAD+ produces more noticeable effects than oral precursors, including improved energy, mental clarity, and exercise recovery.

Mechanism of Action

NAD+ serves as an essential cofactor for three major enzyme families: Sirtuins (SIRT1-7) — NAD+-dependent deacetylases that regulate gene expression, DNA repair, mitochondrial biogenesis, and inflammation. PARPs (Poly ADP-Ribose Polymerases) — consume NAD+ during DNA damage repair. CD38/CD157 — NADases that increase with age and are major drivers of NAD+ decline. Injectable NAD+ directly replenishes the cellular NAD+ pool, immediately supporting these pathways without requiring biosynthetic conversion steps.

Key Benefits

Rapidly restores cellular NAD+ levels beyond what oral precursors achieve
Activates sirtuins (SIRT1-7) for anti-aging gene expression
Enhances mitochondrial function and ATP production
Supports DNA repair via PARP enzyme activation
Improves mental clarity, focus, and cognitive function
Reduces fatigue and improves exercise recovery
May support addiction recovery and neuroregeneration
Modulates inflammatory pathways

Potential Side Effects

Nausea and GI discomfort (especially IV, dose-dependent)
Chest tightness or pressure during IV infusion (rate-dependent)
Flushing and warmth
Headache
Injection site reactions (SubQ)
Muscle cramping
Heart pounding sensation during IV (reduce infusion rate)

Common Stacks

This peptide is commonly combined with the following compounds for synergistic effects:

ResveratrolMetforminRapamycinTMG (Trimethylglycine)CoQ10SS-31

Scientific References

Quick Reference

Typical Dose

SubQ: 50-200mg daily. IV: 250-1000mg per session (infused over 2-4 hours)

Frequency

SubQ: Daily to 3x/week. IV: Weekly to monthly

Route

Subcutaneous injection or intravenous infusion

Half-Life

~30-45 minutes (plasma), but tissue effects persist much longer

Cycle Length

Ongoing — many protocols run 3-6 months with periodic breaks

FDA Status

Not FDA approved as a drug; used as a compounded preparation

Need to calculate dosing?

Use our reconstitution calculator to determine exact syringe measurements.

Open Calculator

This information is for educational purposes only. Consult a qualified healthcare professional before using any peptide. Dosing information reflects commonly reported protocols and may not be appropriate for everyone.

Related Peptides in Longevity & Anti-Aging